The Outcome of Salvage Liver Transplantation and Liver Resection for Recurrent Hepatocellular Carcinoma Using the 5-5-500 Rule, Japanese Extended Liver Transplantation Criteria for Hepatocellular Carcinoma

被引:1
|
作者
Hirata, Yoshihiro [1 ,3 ]
Kotera, Yoshihito [1 ]
Kato, Takaaki [1 ]
Ariizumi, Syunichi [1 ]
Kogiso, Tomomi
Tokushige, Katsutoshi [2 ]
Honda, Goro [1 ]
Egawa, Hiroto [1 ]
机构
[1] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Hepatobiliary Pancreat Surg, Shinjuku Ku, Tokyo, Japan
[2] Tokyo Womens Med Univ, Inst Gastroenterol, Shinjuku Ku, Tokyo, Japan
[3] Tokyo Womens Med Univ, 8-1, Kawada Cho,Shinjuku Ku, Tokyo 1628666, Japan
关键词
REPEAT HEPATECTOMY; TUMOR SIZE; IMPACT;
D O I
10.1016/j.transproceed.2023.04.028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Liver transplantation (LT) for hepatocellular carcinoma (HCC) is limited to Child-Pugh class C patients according to the Japanese HCC treatment algorithm. However, extended criteria of LT for HCC, known as the 5-5-500 rule, were published in 2019. Hepatocellular carcinoma reportedly has a high recurrence rate after primary treatment. We hypothesized that the outcome of recurrent HCC would be improved if the 5-5-500 rule were adopted for patients with recurrent HCC. We, therefore, analyzed the outcomes of surgical treatment (liver resection [LR] and LT) for recurrent HCC using the 5-5-500 rule in our institute.Methods. Fifty-two patients younger than 70 years of age received surgical treatment for recurrent HCC using our institute's 5-5-500 rule from 2010 to 2019. We divided these patients into the LR and LT groups in the first study. The 10-year overall survival and re-recurrence-free survival were analyzed. The second study analyzed the risk factors of re-recurrence after surgical treatment for recurrent HCC.Results. In the first study, the background characteristics of the 2 groups (LR and LT) showed no significant difference, except for age and Child-Pugh classification. There was no significant difference in the overall survival between groups (P = .35), but the re-recurrence-free survival in the LR group was significantly shorter than that in the LT group (P < .01). In the second study, the male sex and LR were risk factors of re-recurrence after surgical treatment for recurrent HCC. Child-Pugh's class did not contribute to re-recurrence. Conclusions. To improve the outcomes of recurrent HCC, LT is the better choice, regardless of the Child-Pugh class.
引用
收藏
页码:901 / 905
页数:5
相关论文
共 50 条
  • [41] The prognosis and treatment outcomes of patients with recurrent hepatocellular carcinoma after liver transplantation
    Roh, Young-Nam
    Kwon, Choon Hyuck David
    Song, Sanghyun
    Shin, Milljae
    Kim, Jong Man
    Kim, Sungjoo
    Joh, Jae-Won
    Lee, Suk-Koo
    CLINICAL TRANSPLANTATION, 2014, 28 (01) : 141 - 148
  • [42] Is Downstaging Prior to Liver Transplantation Important in Hepatocellular Carcinoma?
    Lee, P.
    Kee, S.
    Busuttil, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (08) : 1703 - 1704
  • [43] Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation
    Ladabaum, Uri
    Cheng, Shan L.
    Yao, Francis Y.
    Roberts, John P.
    CLINICAL TRANSPLANTATION, 2011, 25 (02) : 283 - 291
  • [44] Liver Transplantation and Liver Resection for Cirrhotic Patients with Hepatocellular Carcinoma: Comparison of Long-Term Survivals
    Krenzien, Felix
    Schmelzle, Moritz
    Struecker, Benjamin
    Raschzok, Nathanael
    Benzing, Christian
    Jara, Maximilian
    Bahra, Marcus
    Oellinger, Robert
    Sauer, Igor M.
    Pascher, Andreas
    Pratschke, Johann
    Andreou, Andreas
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (05) : 840 - 848
  • [45] Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation
    Choi, Ho Joong
    Kim, Dong Goo
    Na, Gun Hyung
    Han, Jae Hyun
    Hong, Tae Ho
    You, Young Kyoung
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (29) : 4737 - 4744
  • [46] Time to Transplantation as a Predictor of Hepatocellular Carcinoma Recurrence After Liver Transplantation
    Samoylova, Mariya L.
    Dodge, Jennifer L.
    Yao, Francis Y.
    Roberts, John Paul
    LIVER TRANSPLANTATION, 2014, 20 (08) : 937 - 944
  • [47] Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection
    Chan, Kun-Ming
    Wu, Tsung-Han
    Cheng, Chih-Hsien
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chou, Hong-Shiue
    Lee, Wei-Chen
    BIOMEDICAL JOURNAL, 2019, 42 (05) : 335 - 342
  • [48] Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation
    Hollebecque, A.
    Decaens, T.
    Boleslawski, E.
    Mathurin, P.
    Duvoux, C.
    Pruvot, F. -R.
    Dharancy, S.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 (05): : 361 - 369
  • [49] Characteristics and outcome of incidental hepatocellular carcinoma after liver transplantation: a cohort study
    Rios Leon, Raquel
    Sanchez Rodriguez, Eugenia
    Martinez Ortega, Antonio
    Rodriguez de Santiago, Enrique
    Marcos Carrasco, Natalia
    Graus Morales, Javier
    Rodriguez Gandia, Miguel Angel
    Lledo Navarro, Jose Luis
    Gea Rodriguez, Francisco
    Vazquez Garza, Javier Maria Nuno
    Albillos Martinez, Agustin
    Garcia Gonzalez, Miguel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (04) : 219 - 225
  • [50] Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
    Kim, Deok Gie
    Dong, Jae Geun
    Joo, Dong Jin
    Kim, Soon Il
    Kim, Myoung Soo
    SCIENTIFIC REPORTS, 2019, 9 (1)